| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -3.58% | -1.08% | -2.50% | -2.50% | — |
| 14d | 2 | +100.00% | -16.03% | -3.02% | -13.01% | -13.01% | — |
| 30d | 2 | +100.00% | -30.18% | -5.45% | -24.73% | -24.73% | — |
| 60d | 2 | +100.00% | -50.93% | -4.83% | -46.10% | -46.10% | — |
| 90d | 2 | +100.00% | -53.26% | +3.14% | -56.40% | -56.40% | — |
| 180d | 2(1 pending) | +100.00% | -5.20% | +5.52% | -10.72% | -10.72% | — |
| 1y | 2(1 pending) | +0.00% | +107.51% | +12.57% | +94.94% | +94.94% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NMRA NEUMORA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,436 | $3.57 | $5.1K | 21,034 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Jan 8, 2026 | Jan 9, 2026 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 400,000 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 28,675 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 38,234 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,675 | — | — | 28,675 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 85,391 | — | — | 85,391 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 41,250 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 85,391 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,250 | — | — | 41,250 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,234 | — | — | 38,234 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,978 | $1.69 | $3.4K | 22,470 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 41,250 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,234 | — | — | 38,234 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 38,234 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 85,391 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,250 | — | — | 41,250 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 85,391 | — | — | 85,391 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE See Remarks | 28,675 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,675 | — | — | 28,675 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,250 | — | — | 41,250 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,625 | — | — | 24,448 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |